- Pentaerythrite tetranitrate
- C 2
- Pentaerythritol tetranitrate with 80% d-Lactose monohydrate
- 2,2-Bisdihydroxymethyl-1,3-propanediol tetranitrate
White crystals mixed with more than 7% wax.
Mainly in the Manufacture of detonating fuse (primacord), a waterproof textile filled with powdered petn.
Registry Numbers and Inventories.
EC Index Number
Tumorigen; Drug; Mutagen; Human Data
Japan ENCS (MITI)
Melting point, °C
Boiling point, °C
Vapor pressure, mmHg
4E-7 (25 C)
Solubility in water
Partition coefficient, pKow
Heat of fusion
Heat of vaporization
Hazards and Protection.
Store below 40C (104F), preferably between 15 and 30C (59 and 86F), unless otherwise specified by manufacturer. Store in a tight container. Store in a cool place in a airtight container. Protect from light.
All chemicals should be considered hazardous. Avoid direct physical contact. Use appropriate, approved safety equipment. Untrained individuals should not handle this chemical or its container. Handling should occur in a chemical fume hood.
Wear appropriate protective gloves, clothing and goggles.
Wear positive pressure self-contained breathing apparatus (SCBA).
Keep sparks, flames, and other sources of ignition away. Keep material wet. Wet spilled material before picking it up. Do not attempt to sweep up dry material.
If mixed with reducing agents, including hydrides, sulfides and nitrides.
Dangerously explosive. Do not fight fires in a cargo of explosives. Evacuate area and let burn.
This material is probably combustible.
May ignite on contact with moist air or moisture. May burn rapidly with flare-burning effect. May react vigorously or explosively on contact with water. May decompose explosively when heated or involved in a fire. May re-ignite after fire is extinguished.
Fire will produce irritating, corrosive and/or toxic gases.
Abnormally low blood pressure is common. Low heart rate may occur in predisposed patients; reflex rapid heart rate may occur. Death occurs secondary to circulatory collapse or respiratory failure. With therapeutic use - 1. Headache and dizziness are common, even after administration of therapeutic doses. Acute wernicke's encephalopathy from intravenous infusions may be precipitated by ethanol and propylene glycol diluents. In male rats, a dominant lethal test showed no effect on male fertility; interstitial cell tumors of rat testes were induced after nitroglycerin exposure. Results on teratogenicity in rats are conflicting.
Nausea, vomiting, colicky pain, and diarrhea may occur.
Inhalation of decomposition products may cause severe injury or death.
Contact with substance may cause severe burns.
LOSS OF VISION - A transient loss of vision reportedly occurred before acute toxic effects from nitroglycerin exposure. Constriction of the pupil and corneal damage occurred after intravenous exposure.
If the exposed person is convulsing or unconscious, do not attempt first aid. Transport immediately to a hospital emergency room or poison control center. If the victim is conscious, DO NOT INDUCE VOMITING. Transport to a medical facility.
If any of your laboratory personnel should inhale this chemical, remove them at once to open air and arrange for immediate transportation to a medical facility.
You should remove all contaminated clothing and flood skin with water. Wash all affected skin areas thoroughly with soap and water. If symptoms persist or develop, seek medical attention.
Check for contact lenses and remove them at once if present. You should then immediately flush eyes with water for 15 minutes. Do not use oil or ointment in eyes. Arrange immediate transportation to a medical facility.
Std. Transport #